TipRanks
Psyence Biomedical (PBM)
NASDAQ:PBM
US Market
PBM
Psyence Biomedical
RESEARCH TOOLSreports

Psyence Biomedical (PBM) Income Statement

277 Followers

Psyence Biomedical Income Statement

Last quarter (Q3 2023), Psyence Biomedical's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q3, Psyence Biomedical's net income was C$-24.76M. See Psyence Biomedical’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Mar 25Mar 24Mar 23Mar 22
Total Revenue
$ 0.00$ 0.00$ 0.00C$ 0.00C$ 0.00
Gross Profit
$ -5.27K$ -4.27K$ -240.00C$ 0.00C$ 0.00
Operating Expenses
$ 6.24M$ 3.66M$ 2.75MC$ 1.29MC$ 334.29K
Depreciation and Amortization
$ 5.27K$ 4.27K$ 240.00C$ 0.00C$ 2.32M
EBITDA
$ -6.92M$ 1.03M$ -51.11MC$ 10.77MC$ 10.49M
Operating Income
$ -6.24M$ -3.66M$ -2.75MC$ -4.38MC$ -334.29K
Other Income/Expenses
$ -698.91K$ 4.67M$ -48.41MC$ 38.50KC$ 8.56M
Pretax Income
$ -6.94M$ 1.01M$ -51.16MC$ 8.01MC$ 8.23M
Net Income
$ -6.94M$ 1.01M$ -51.16MC$ 8.01MC$ 8.23M
Per Share Metrics
Basic EPS
$ -12.56$ 1.78$ -7.85C$ -0.64C$ 0.25
Diluted EPS
$ -12.56$ 1.78$ -7.85C$ -0.64C$ 0.25
Weighted Average Shares Outstanding
 552.28K 568.02K 6.52M 32.67M 32.67M
Weighted Average Shares Outstanding (Diluted)
 552.28K 568.02K 6.52M 32.67M 32.67M

Psyence Biomedical Earnings and Revenue History